Moderna is a leader in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. With its breakthrough platform, Moderna is creating mRNA medicines for a wide range of diseases and conditions, in many cases by addressing currently undruggable targets or underserved areas of medical need. Moderna is developing its innovative mRNA medicines for infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases, through solely controlled programs and collaborations with strategic partners. Headquartered in Cambridge, Mass., privately held Moderna currently has strategic relationships with AstraZeneca, Plc. (AZ), Merck, Inc (MRK) and Vertex Pharmaceuticals (VRTX), as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense; the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS); and the Bill & Melinda Gates Foundation. In 2017 Moderna was ranked a top biopharma industry employer by Science Magazine and a Top Place to Work by the Boston Globe. To learn more, visit www.modernatx.com.
View Top Employees from Moderna TherapeuticsWebsite | http://www.modernatx.com |
Ticker | MRNA |
Revenue | $20.7 billion |
Funding | $5.2 billion |
Employees | 5,584 (5,584 on RocketReach) |
Founded | 2010 |
Address | 200 Technology Sq, Cambridge, Massachusetts 02139, US |
Phone | (617) 714-6500 |
Fax | (617) 583-1998 |
Technologies |
JavaScript,
HTML,
Twitter
+108 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare, Science and Engineering, Mrna Therapeutics, Genetics, Health Care, Medical, Pharmaceutical |
Web Rank | 1 Million |
Keywords | Infectious Disease, Immuno-Oncology, Rare Disease, Cardiovascular Services |
Competitors | Alnylam Pharmaceuticals, Emergent BioSolutions, Exelixis, Kite Pharma, OPKO Health, Inc. |
SIC | SIC Code 873 Companies, SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 5419 Companies, NAICS Code 541990 Companies, NAICS Code 54199 Companies, NAICS Code 32 Companies |
Looking for a particular Moderna Therapeutics employee's phone or email?
The Moderna Therapeutics annual revenue was $20.7 billion in 2024.
Roland Smith is the Chief Architect, Vice President of Moderna Therapeutics.
5,584 people are employed at Moderna Therapeutics.
Moderna Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for Moderna Therapeutics are [54, 541, 325, 5419, 541990, 54199, 32].
The SIC codes for Moderna Therapeutics are [873, 283, 28, 87].